5-HT2 receptor blockade to study serotonin-induced pathology
- 1 January 1983
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 4, 198-206
- https://doi.org/10.1016/0165-6147(83)90365-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Does 5-hydroxytryptamine play a role in hypertension?Trends in Pharmacological Sciences, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468)European Journal of Pharmacology, 1982
- The Antihypertensive Effects of Ketanserin (R 41 468), a Novel 5-Hydroxytryptamine-Blocking Agent, in Patients with Essential HypertensionClinical Science, 1981
- 5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILUREThe Lancet, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981